Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

VC Deals Analysis: 2018 Off To A Flying Start

Executive Summary

Venture financing activity hit the ground running in 2018 after a bumper haul of mega-raises brought the total deal value for January close to $1bn.

You may also be interested in...



VC Deals Analysis: Asia Investors Pour Money Into Grail And May's Other Big Deals

Asian investors' unrelenting pursuit of medtech ventures continued to crescendo in May. The participants in the largest round so far this year, the $300m series C by Illumina spin-out Grail, are all China-based funds.

Boston Scientific Hooks In Millipede, But Still Trailing Behind In Mitral Valve Race

Boston Scientific is pumping money into the high-potential mitral valve repair space by making a strategic investment in Millipede, as well as signing an acquisition option agreement that could be worth nearly half a billion dollars. However, its cardiovascular rivals are already some distance ahead in this space.

Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?

Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT122184

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel